Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles

Virology

Volumn 259, Issue 1, 1999, Pages 148-153

  Herrmann, John E ^a   Chen, Shing C ^a   Jones, David H ^b   Tinsley Bown, Anne ^b   Fynan, Ellen F ^a,c   Greenberg, Harry B ^d   Farrar, Graham H ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c WORCESTER STATE UNIVERSITY   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; DNA VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; POLYGLACTIN; ROTAVIRUS VACCINE; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FECES; IMMUNE RESPONSE; IMMUNIZATION; MICROENCAPSULATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PRIORITY JOURNAL; PROTECTION; ROTAVIRUS;

EID: 0033587314     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9751     Document Type: Article

References (33)

1. Bishop R. F. Development of candidate rotavirus vaccines. Vaccine. 11:1993;247-254.
2. Chen S. C., Fynan E. F., Robinson H. L., Lu S., Greenberg H. B., Santoro J. C., Herrmann J. E. Protective immunity induced by rotavirus DNA vaccines. Vaccine. 15:1997;899-902.
3. Chen S. C., Jones D. H., Fynan E. F., Farrar G. H., Clegg J. C. S., Greenberg H. B., Herrmann J. E. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J. Virol. 72:1998;5757-5761.
4. Choi A. H.-C., Basu M., Tae M. N., McNeal M. M., Ward R. L. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge. Virology. 250:1998;230-240.
5. Coulson B. S., Grimwood K., Hudson I. L., Barnes G. L., Bishop R. F. Role of coproantibody in clinical protection of children during reinfection with rotavirus. J. Clin. Microbiol. 30:1992;1678-1684.
6. Desai M. P., Labhasetwar V., Amidon G. L., Levy R. J. Gastrointestinal uptake of biodegradable microparticles: Effect of particle size. Pharm. Res. 13:1996;1838-1845.
7. Estes M. R., Cohen J. Rotavirus gene structure, and function. Microbiol. Rev. 53:1989;410-449.
8. Eldridge J. H., Meulbroek J. A., Staas J. K., Tice T. R., Gilley R. M. Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response. Adv. Exp. Med. Biol. 251:1989;91-202.
9. Etchart N. Buckland R., Liu M., Wild T. F., Kaiserlain D. Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin. J. Gen. Virol. 78:1996;1577-1580.
10. Feng N., Burns J. W., Bracy L., Greenberg H. B. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J. Virol. 68:1994;7766-7773.
11. Fynan E. F., Webster R. G., Fuller D. H., Haynes J. R., Santoro J. C., Robinson H. L. DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA. 90:1993;11478-11482.
12. Glass R. I., Gentsch J. R., Ivanoff B. New lessons for rotavirus vaccines. Science. 272:1996;46-48.
13. Herrmann J. E., Chen S. C., Fynan E. F., Santoro J. C., Greenberg H. B., Robinson H. L. Protection against rotavirus infections by DNA vaccination. J. Infect. Dis. 174:1996a;S93-97.
14. Herrmann J. E., Chen S. C., Fynan E. F., Santoro J. C., Greenberg H. B., Robinson H. L. DNA vaccines against rotavirus infections. Arch. Virol. Suppl. 12:1996b;207-215.
15. Jepson M. A., Clark M. A., Foster N., Mason C. M., Bennet M. K., Simmons N. L., Hirst B. H. Targeting to intestinal M cells. J. Anat. 189:1996;507-516.
16. Jepson M. A., Simmons N. L., O'Hagen D. T., Hirst B. H. Comparison of poly (DL-lactide-co-glycolide) and polystyrene microsphere targeting to intestinal M cells. J. Drug Targeting. 1:1993;245-249.
17. Jones D. H., Clegg J. C. S., Farrar G. H. Oral delivery of microencapsulated DNA vaccines. Dev. Biol. Stand. 92:1997a;149-155.
18. Jones D. H., Corris S., McDonald S., Clegg J. C. S., Farrar G. H. Poly (DL-lactide co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine. 15:1997b;814-817.
19. Jones D. H., McBride B. W., Thorntin C., O'Hagen D. T., Robinson A., Farrar G. H. Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. Pertussis respiratory infection. Infect. Immun. 64:1996;489-494.
20. Keusch G. T., Cash R. A. A vaccine against rotavirus-when is too much too much. N. Engl. J. Med. 337:1997;1228-1229.
21. Lanata C. F., Midthun K., Black R. E., Butron B., Huapaya A., Penny M. E., Ventura G., Gil A., Jett-Goheen M., Davidson B. L. Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus-human, reassortant rotavirus vaccine in infants in Lima, Peru. J. Infect. Dis. 174:1996;268-275.
22. Linhares A. C., Gabbay Y. B., Mascarenhas J. D., de Freitas R. B., Oliveira C. S., Bellesi N., Monteiro T. A., Lins-Lainson Z., Ramos F. L., Valente S. A. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belem, Brazil. Bull. World Health Org. 74:1996;491-500.
23. McNeal M. M., Broome R., Ward R. L. Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination. Virology. 204:1994;642-650.
24. Matson D. O., O'Ryan M., Herrera L. I., Pickering L. K., Estes M. K. Fecal antibody responses to symptomatic and asymptomatic rotavirus infections. J. Infect. Dis. 167:1993;577-583.
25. O'Hagen D. T. The intestinal uptake of particles and the implications for drug and antigen delivery. J. Anat. 189:1996;477-482.
26. O'Neal C. M., Crawford S. E., Estes M. K, Conner M. E. Rotavirus virus-like particles administered mucosally induce protective immunity. J. Virol. 71:1997;8787-9717.
27. Pérez-Schael I., Guntinas M. J., Perez M., Pagone V., Rojas A. M., Gonzalez R., Cunto W., Hoshino Y., Kapikian A. Z. Efficacy of the rhesus rotavirus-based quadravalent vaccine in infants and young children in Venezuela. N. Engl. J. Med. 337:1997;1181-1187.
28. Vesikari T. Rotavirus vaccines against diarrhoeal disease. Lancet. 350:1997;1538-1541.
29. Ward R. L. Mechanism of protection against rotavirus in humans and mice. J. Infect. Dis. 174:1996;S47-50.
30. Ward R. L., McNeal M. M., Sheridan R. F. Development of an adult mouse model for studies on protection against rotavirus. J. Virol. 64:1990;5070-5075.
31. Webster R. G., Fynan E. F., Santoro J. C., Robinson H. L. Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine. 12:1994;1495-1498.
32. Yasutomi Y., Robinson H. L., Lu S., Mustafa F., Lekutis C., Arthos J., Mullins J. I., Voss G., Manson K., Wyand M., Letvin N. L. Simian immunodeficiency virus-specific cytotoxic T lymphocyte induction through DNA vaccination of rhesus monkeys. J. Virol. 70:1996;678-681.
33. Yuan L., Ward L. A., Rosen B. I., To T. L., Saif L. J. Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J. Virol. 70:1996;3075-3083.